Study details
Enrolling now
Whole Body DWI vs. FDG PET
University of California, San Francisco
NCT IDNCT06630845ClinicalTrials.gov data as of Apr 2026
Target enrollment
30
Study length
about 4.7 years
Ages
18+
Locations
1 site in CA
What this study is about
Researchers are testing whether whole body diffusion weight imaging (DWI) is a better way to detect cancer than 18F-fludeoxyglucose (FDG) PET/MRI in people with metastatic cancer. The trial will last for about 1728 days and involve approximately 30 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Fluorodeoxyglucose F18
- 2.Undergo Positron Emission Tomography combined with Magnetic resonance imaging (PET/MRI)
- 3.Undergo Whole Body Magnetic Resonance Imaging with Diffusion-Weighted Imaging (WB-MRI-DWI)
- +1 more
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
fludeoxyglucose (18F)
Endpoints
Secondary: Inter-reader variability of diffusion weight imaging (DWI) interpretation
Procedures
imaging